Theravance Biopharma (TBPH) Other financing activities (2014 - 2026)
Theravance Biopharma (TBPH) reported Other financing activities of $2.1 million for Q2 2026, up 318.3% from $503,000 a year earlier but down 63.8% from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Other financing activities (2014 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Theravance Biopharma's Other financing activities came in at $10.58 million, up 359.6% year-over-year; for FY2025, it came in at $4.03 million, up 51.7% from FY2024.
- Other financing activities has a five-year compound annual growth rate of -16.2% (FY2020 to FY2025).
- By year, Other financing activities came in at $2.66 million in FY2024 (+6.4%), $2.5 million in FY2023 (-27.5%), $3.45 million in FY2022 (-61.9%) and $9.06 million in FY2021 (-7.1%).
- Five-year quarterly Other financing activities spans a low of $347,000 in Q2 2022 and a high of $5.82 million in Q1 2026.
- Year over year, Other financing activities has now increased in each of the last five quarters, with growth averaging 148.3% over the last eight quarters.
- The high point for year-over-year Other financing activities in five years was Q1 2026 (growth of 565.7%); the low point was Q1 2022 (a decline of 74.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.82 million (Q1 2026), $1.98 million (Q4 2025) and $678,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.10 Mn |
| Mar 31, 2026 | 5.82 Mn |
| Dec 31, 2025 | 1.98 Mn |
| Sep 30, 2025 | 678,000.00 |
| Jun 30, 2025 | 503,000.00 |
| Mar 31, 2025 | 874,000.00 |
| Dec 31, 2024 | 528,000.00 |
| Sep 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 464,000.00 |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 518,000.00 |
| Sep 30, 2023 | 512,000.00 |
| Jun 30, 2023 | 583,000.00 |
| Mar 31, 2023 | 887,000.00 |
| Dec 31, 2022 | 993,000.00 |
| Sep 30, 2022 | 662,000.00 |
| Jun 30, 2022 | 347,000.00 |
| Mar 31, 2022 | 1.45 Mn |
| Dec 31, 2021 | 455,000.00 |
| Sep 30, 2021 | 2.29 Mn |
API Access
Theravance Biopharma Other financing activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-financing-activities", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-financing-activities&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();